Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2
暂无分享,去创建一个
Bin Wang | You-hong Cui | X. Bian | Y. Ping | Y. Shi | W. Cui | L. Yang | Zhe Wang | Qing-liang Wang | H. Kung | Y Shi | L Yang | Lang Yang | Yu Shi | X Zhang | Chuan Xu | Z. Wang | B. Wang | C. Xu | H. Xiao | L. Ma | S. Xu | Q. Wang | W. Dang | S. C. Yu | Y. Cui | C. Qian | X. Zhang | Z Wang | B Wang | C Xu | H L Xiao | L N Ma | S L Xu | Q L Wang | W Q Dang | W Cui | S C Yu | Y F Ping | Y H Cui | H F Kung | C Qian | X W Bian | Wei Cui | Sen-lin Xu | Chengwei Qian | Xi Zhang | Hualiang Xiao | Shi-cang Yu | S. Yu | S. Yu | Bin Wang | Zhe Wang
[1] You-hong Cui,et al. β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma. , 2013, Cancer research.
[2] You-hong Cui,et al. TGF-β1 enhances tumor-induced angiogenesis via JNK pathway and macrophage infiltration in an improved zebrafish embryo/xenograft glioma model. , 2013, International immunopharmacology.
[3] Isabelle Salmon,et al. A Simplified Approach for the Molecular Classification of Glioblastomas , 2012, PloS one.
[4] Peng Zhang,et al. Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF-β1 Signaling Pathway , 2012, The Journal of Immunology.
[5] M. Caraglia,et al. Editorial [Hot Topic: Target Therapy in Brain Tumours and Metastases (Guest Editors: M. Caraglia and R. Addeo)] , 2012 .
[6] Yu Zhao,et al. Lipid metabolism enzyme 5-LOX and its metabolite LTB4 are capable of activating transcription factor NF-κB in hepatoma cells. , 2012, Biochemical and biophysical research communications.
[7] C. Croce. miRNAs in the spotlight: Understanding cancer gene dependency , 2011, Nature Medicine.
[8] Danish Sayed,et al. MicroRNAs in development and disease. , 2011, Physiological reviews.
[9] Bin Wang,et al. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell‐mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling , 2011, The Journal of pathology.
[10] X. Bian,et al. Concise Review: Contribution of Cancer Stem Cells to Neovascularization , 2011, Stem cells.
[11] Bin Wang,et al. An Inhibitor of Arachidonate 5-Lipoxygenase, Nordy, Induces Differentiation and Inhibits Self-Renewal of Glioma Stem-Like Cells , 2011, Stem Cell Reviews and Reports.
[12] R. Jain,et al. PDGF-D Improves Drug Delivery and Efficacy via Vascular Normalization, But Promotes Lymphatic Metastasis by Activating CXCR4 in Breast Cancer , 2011, Clinical Cancer Research.
[13] K. Kelnar,et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. , 2011, Nature medicine.
[14] Ping Yf,et al. Cancer stem cells switch on tumor neovascularization. , 2011 .
[15] M. Cleary,et al. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. , 2010, Cancer research.
[16] Michael F. Clarke,et al. Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.
[17] S. Missailidis,et al. Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. , 2009, International immunopharmacology.
[18] Andrew D Norden,et al. Therapeutic strategies for inhibiting invasion in glioblastoma , 2009, Expert review of neurotherapeutics.
[19] X. Bian,et al. Enrichment of Cancer Stem Cells Based on Heterogeneity of Invasiveness , 2009, Stem Cell Reviews and Reports.
[20] Fedor V. Karginov,et al. The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma , 2009, Proceedings of the National Academy of Sciences.
[21] G. I. Gallicano,et al. miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. , 2009, Developmental biology.
[22] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[23] F. Slack,et al. MicroRNA in cancer prognosis. , 2008, The New England journal of medicine.
[24] Agnieszka Bronisz,et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. , 2008, Cancer research.
[25] X. Bian,et al. Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G‐protein coupled formylpeptide receptor FPR , 2008, The Journal of pathology.
[26] X. Bian,et al. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. , 2008, Cancer letters.
[27] Claudia Petritsch,et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .
[28] M. Westphal,et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.
[29] J. Mendell. miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.
[30] W. Henderson,et al. Mechanisms of disease: Leukotrienes , 2007 .
[31] Sriram Krishnamoorthy,et al. Lipoxygenase metabolism: roles in tumor progression and survival , 2007, Cancer and Metastasis Reviews.
[32] J. M. Thomson,et al. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. , 2007, Developmental biology.
[33] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[34] X. Bian,et al. Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma , 2007, Modern Pathology.
[35] X. Bian,et al. Unique proteomic features induced by a potential antiglioma agent, Nordy (dl‐nordihydroguaiaretic acid), in glioma cells , 2008, Proteomics.
[36] M. Berens,et al. Molecular targets of glioma invasion , 2007, Cellular and Molecular Life Sciences.
[37] A. Habenicht,et al. What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? , 2006, International journal of cancer.
[38] Harikrishna Nakshatri,et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis , 2006, Breast Cancer Research.
[39] Anwar Hossain,et al. Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.
[40] C. Croce,et al. MicroRNA-cancer connection: the beginning of a new tale. , 2006, Cancer research.
[41] Tara L. Naylor,et al. microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[42] X. Bian,et al. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells. , 2006, Biochemical and biophysical research communications.
[43] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[44] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[45] R. Plasterk,et al. MicroRNA function in animal development , 2005, FEBS letters.
[46] G. Maira,et al. Extensive modulation of a set of microRNAs in primary glioblastoma. , 2005, Biochemical and biophysical research communications.
[47] K. Kosik,et al. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.
[48] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[49] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[50] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[51] F. Davis,et al. Current epidemiological trends and surveillance issues in brain tumors , 2001, Expert review of anticancer therapy.
[52] M. Fukuzawa,et al. Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome. , 1998, Journal of pediatric surgery.
[53] H. Shimada,et al. Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. , 1996, Cancer research.
[54] L. Liotta,et al. Tumor cell invasion inhibited by TIMP-2. , 1991, Journal of the National Cancer Institute.
[55] H. Shimada,et al. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. , 1991, Cancer research.
[56] M. Caraglia,et al. Editorial: target therapy in brain tumours and metastases. , 2012, Current cancer drug targets.
[57] Y. Ping,et al. Cancer stem cells switch on tumor neovascularization. , 2011, Current molecular medicine.
[58] M. Cleary,et al. The miR-1792 microRNA Polycistron Regulates MLL Leukemia Stem Cell Potential by Modulating p 21 Expression , 2010 .
[59] J. Massagué,et al. Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.
[60] Zang Ai-hua,et al. Stem Cells,Cancer and Cancer Stem Cells , 2005 .
[61] E F Heineman,et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. , 1999, Journal of the National Cancer Institute.